201849-21-0

Basic information

• Product Name: 2-(4'-BROMO-2'-CHLOROPHENOXY)PROPANE
• Synonyms: 2-(4'-BROMO-2'-CHLOROPHENOXY)PROPANE;4-BROMO-2-CHLORO-1-ISOPROPOXYBENZENE;4-bromo-2-chloro-1-propan-2-yloxybenzene
• CAS NO: 201849-21-0
• Molecular Formula: C₉H₁₀BrClO
• Molecular Weight: 249.53
• Mol File: 201849-21-0.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 269.5±20.0 °C(Predicted)
• Appearance: /
• Density: 1.426±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2-(4'-BROMO-2'-CHLOROPHENOXY)PROPANE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4'-BROMO-2'-CHLOROPHENOXY)PROPANE(201849-21-0)
• EPA Substance Registry System: 2-(4'-BROMO-2'-CHLOROPHENOXY)PROPANE(201849-21-0)

Safety Data

• Hazardous Substances Data: 201849-21-0(Hazardous Substances Data)

Usage

General Description

2-(4'-Bromo-2'-chlorophenoxy)propane is a chemical compound with the molecular formula C9H10BrClO. It is a colorless liquid that is used as an intermediate in the synthesis of other chemicals, particularly in the production of pharmaceuticals and agrochemicals. The compound is a halogenated derivative of propylbenzene, and it is primarily used as a reagent in organic synthesis, including in the production of pesticides and herbicides. It is important to handle this compound with care, as it can be hazardous if not properly managed.

Upstream product

• 75-30-9 2-iodo-propane 
• 3964-56-5 4-bromo-2-chlorophenol 
• 75-26-3 isopropyl bromide 

Downstream Products

• 1344997-80-3 methyl 1-{2-[3-(2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,3-thiazol-5-yl)-2-ethylphenyl]ethyl}-3-azetidinecarboxylate 
• 1344997-79-0 ethyl 1-{2-[3-(2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,3-thiazol-5-yl)-2-ethylphenyl]ethyl}-4-piperidinecarboxylate 
• 1344997-78-9 methyl 1-{[3-(2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,3-thiazol-5-yl)-2-ethylphenyl]methyl}-3-azetidinecarboxylate 
• 1344997-75-6 ethyl 1-{[3-(2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,3-thiazol-5-yl)-2-ethylphenyl]methyl}-4-piperidinecarboxylate 
• 1344997-72-3 methyl 1-{2-[3-(2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,3-thiazol-5-yl)-5-fluoro-2-(methyloxy)phenyl]ethyl}-3-azetidinecarboxylate 
• 1344997-70-1 [3-(2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,3-thiazol-5-yl)-5-fluoro-2-(methyloxy)phenyl]acetaldehyde 
• 1344997-69-8 2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-5-{5-fluoro-2-(methyloxy)-3-[(E)-2-(methyloxy)ethenyl]phenyl}-1,3-thiazole 
• 1260024-00-7 [3-(2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,3-thiazol-5-yl)-2-ethylphenyl] acetaldehyde 
• 1260023-98-0 2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-5-{2-ethyl-3-[(E)-2-(methyloxy)ethenyl]phenyl}-1,3-thiazole 
• 1260023-93-5 3-(2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,3-thiazol-5-yl)-2-ethylbenzaldehyde 
• 1258440-40-2 5-bromo-2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,3-thiazole 
• 1258440-38-8 2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,3-thiazole 
• 1334607-75-8 4-{[3-(2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-5-pyrimidinyl)-2-ethylphenyl]oxy}butanoic acid 
• 1334608-21-7 ethyl 4-{[3-(2-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-5-pyrimidinyl)-2-ethylphenyl]oxy}butanoate 

Relevant articles and documents

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and compounds I for use to treat or prevent diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).

NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES

The present invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.